Discover Seventure's video
Vedanta Biosciences announces initiation of Phase 1a/1b trial for new drug class of rationally-defined bacteria consortia derived from the human microbiome
VE303 is first known rationally-defined bacterial...
Vedanta Biosciences Expands Network of Clinical Collaborations Supporting Development of Microbiome Therapeutics for Cancer Immunotherapy
New collaborations with Leiden University Medical Center...
Enhanced understanding of the microbiome is helping medicine via The Economist
Enterome, Eligo Bioscience and Seventure Partners inside...
Scipio bioscience announces its seed funding of €1.2m obtained from Seventure Partners’ Quadrivium I seed fund and High-Tech Gründerfonds
Scipio bioscience, a Paris-based biotechnology company...
Seventure Partners announces the trade sale of its portfolio company Cambrooke Therapeutics, Inc. to Ajinomoto Co. Inc
Seventure Partners, one of Europe’s leaders in...
J.P. Morgan 36th Annual Healthcare Conference 2018 San Francisco
More information: http://bit.ly/2qXO07C